Danish biopharmaceutical firm H. Lundbeck A/S, which focuses on brain health, said Friday it will establish an innovation hub in Greater Boston and relocate its U.S. headquarters to the region from Deerfield, IL. The transition will occur over the next year. “The US has been an important driver of Lundbeck’s commercial progress and remains central ...
The post Danish Biopharma Firm to Relocate U.S. Headquarters to Boston Area appeared first on Connect CRE .
This content is for informational purposes only and does not constitute investment advice. Always consult with qualified professionals before making investment decisions.
Related Reading
trending_up
market update1m
Solidcore Signs Lease for Fitness Studio at 1695 Second Avenue on Upper East Side
trending_up
market update1m
Foreclosure Auction on Horizon for Dallas Highrise
trending_up
market update1m
Men’s Grooming Club John Allan’s Moves to 4 East 46th Street
Get Daily Insights Like This
Join thousands of CRE investors receiving market updates, deal analysis, and tenant intelligence daily.
Subscribe Free